Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy

NCT00437684 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections
Hepatitis C

Interventions

DRUG: LPV/r
DRUG: PEG-IFNa 2a
DRUG: Ribavirin
DRUG: NUCS

Sponsor

IRCCS San Raffaele

Collaborators

[object Object]
[object Object]